Genicity has completed its Seed Round from Angel investors and Enterprise Ireland and we are starting our series A financing to complete preclinical development of our ENABLR T-cell platform and achieve clinical proof of concept.
test test test test test test test test test
Some Text HereSome Text HereSome Text HereSome Text HereSome Text HereSome Text HereSome Text HereSome Text HereSome Text HereSome Text HereSome Text Here